ResearchMoz

Mexico 2013 Wealth Book: Trends in Millionaire Wealth

WealthInsight
Published Date » 2013-06-13
No. Of Pages » 103
     
  Synopsis  
   
 
 
 This report is the result of WealthInsight’s extensive research covering the high net worth individual (HNWI) population and wealth management market in Mexico 
 The report focuses on HNWI performance between the end of 2007 (the peak before the global financial crisis) and the end of 2012. This enables us to determine how well the country’s HNWIs have performed through the crisis 
 
 
   
  Summary  
     
 There are 145,000 HNWIs and 2,540 UHNWIs in Mexico in 2012.  This report reviews the performance and asset allocations of HNWIs and Ultra HNWIs in Mexico and highlights top-performing cities. It also includes an evaluation of the local wealth management industry. 
   
  Scope  
     
 
 
 Independent market sizing of...
Table of Content

1 Introduction 
1.1 Details of this Report 
1.2 Definitions 

2 Executive Summary 

3 Wealth Sector Fundamentals 
3.1 Political Background 
3.2 Economic Background 
3.3 Benchmarking Mexico Wealth in Context 
3.3.1 World statistics 
3.3.2 Distribution of wealth in Mexico 
3.4 HNWI Volume and Wealth Trends 

4 Findings from the WealthInsight HNWI Database 
4.1 Trends in HNWI Wealth to 2017 
4.1.1 HNWI trend analysis 
4.1.2 Trends of the wealth bands 
4.1.3 Demographic breakdown of HNWI 
4.2 UHNWIs 
4.2.1 UHNWI volume trend analysis 
4.2.2 UHNWI wealth trend analysis 
4.2.3 Demographic breakdown of UHNWIs 
4.2.4 UHNWIs – job titles 
4.2.5 UHNWIs – industry breakdown 
4.2.6 UHNWIs – breakdown by city 
4.2.7 UHNWIs – city population densities 
4.2.8 UHNWIs – smaller cities 
4.2.1 UHNWIs – affluent suburbs 
4.3 UHNWIs – Billionaires 
4.3.1 Billionaire volume trend analysis 
4.3.2 Billionaire wealth trend analysis 
4.3.3 Billionaire per capita net worth trend analysis 
4.3.4 Billionaire demographics 
4.3.5 List of billionaires 
4.4 UHNWIs – Centimillionaires 
4.4.1 Centimillionaire volume trend analysis 
4.4.2 Centimillionaire wealth trend analysis 
4.4.3 Centimillionaire per capita net worth trend analysis 
4.5 UHNWIs – Affluent Millionaires 
4.5.1 Affluent millionaire volume trend analysis 
4.5.2 Affluent millionaire wealth trend analysis 
4.5.3 Affluent millionaire per capita net worth trend analysis 
4.6 Core HNWIs 
4.6.1 Core HNWI volume trend analysis 
4.7 Core HNWIs – Mid-Tier Millionaires 
4.7.1 Mid-tier millionaire volume trend analysis 
4.7.2 Mid-tier millionaire wealth trend analysis 
4.7.3 Mid-tier millionaire per capita net worth trend analysis 
4.8 Core HNWIs – Lower-Tier Millionaires 
4.8.1 Lower-tier millionaire volume trend analysis 
4.8.2 Lower-tier millionaire wealth trend analysis 
4.8.3 Lower-tier millionaire per capita net worth trend analysis 

5 Analysis of Mexican HNWI Investments 
5.1 Analysis by Asset Classes 
5.1.1 Trends in alternative assets 
5.1.2 Trends in “art, wine and wheels” 
5.1.3 Trends of investments in real estate 
5.1.4 Trends of investments in cash and deposits 
5.1.5 Trends of investments in fixed income 
5.1.6 Trends of investments in equity 
5.1.7 Trends of investments in business interests 
5.2 Analysis of Foreign Investments 
5.2.1 Investments in North America (including the Caribbean) 
5.2.2 Investments in Europe (including the UK) 
5.2.3 Investments in Asia-Pacific
5.2.4 Investments in the rest of Latin America 
5.2.5 Investments in Africa 
5.3 Alternative Breakdown: Liquid vs Investable Assets 
5.4 Analysis of Mexican UHNWI Investments 

6 Competitive Landscape of the Wealth Sector 
6.1 Competitive Landscape 
6.1.1 Private banks 
6.1.2 Wealth managers 
6.2 Family Offices 
6.2.1 Offshore wealth 
6.2.2 Saturation by city 
6.3 Wealth Management Industry – Clientele Model and Maturity 
6.4 Behavioral Mapping of Wealth Management and Private Banking Industry in Mexico 
6.5 Pension Fund Industry 

7 Appendix 
7.1 Regulations on Taxes 
7.2 Economic Indicators 
7.2.1 LC to US$ exchange rate 
7.2.2 Real GDP growth 
7.2.3 Per capita GDP 
7.2.4 Domestic market capitalization 
7.2.5 Commodity index 
7.2.6 Foreign direct investment 
7.2.7 Inflation rate 
7.2.8 Interest rate 
7.2.9 Balance of payments 
7.2.10 Stock market performance 
7.3 Wealth Breakdowns 

8 About WealthInsight

List of Tables


Table 1: HNWI Wealth Band and Group Definitions 
Table 2: Mexico: 10 Most Populous States, 2012 
Table 3: Mexico: Largest Cities, 2012 
Table 4: Mexico: HNWIs – Volume Distribution Wealth Pyramid, 2012 
Table 5: Mexico: HNWIs – Wealth Distribution Wealth Pyramid (% share), 2012 
Table 6: Mexico: UHNWI – Gender, 2012 
Table 7: Mexico: UHNWI – Source of Wealth (%), 2012 
Table 8: Mexico: UHNWIs – Top 10 Cities, 2012 
Table 9: Mexico: UHNWIs – Population Density in Top 10 Cities, 2012 
Table 10: Mexico: UHNWIs – Smaller Cities, 2012 
Table 11: Mexico: UHNWIs – Affluent Suburbs, 2012 
Table 12: Mexico: Billionaires – Market Overview (US$ Billion) 2007–2017 
Table 13: Mexico: Top Billionaires (US$ Billion), 2012 
Table 14: Mexico: Top Billionaires (US$ Billion), 2007–2012 39
Table 15: Mexico: Centimillionaires – Market Overview, 2007–2017 
Table 16: Mexico: Affluent Millionaires – Market Overview, 2007–2017 
Table 17: Mexico: Mid-Tier Millionaires – Market Overview, 2007–2017 
Table 18: Mexico: Lower-Tier Millionaires – Market Overview, 2007–2017 
Table 19: Mexico: Allocations of HNWI Assets (%), 2007−2017 
Table 20: Mexico: HNWIs − Holdings Growth (%), 2007–2017 
Table 21: Mexico: HNWIs – Trends of Investments in Alternative Assets (%), 2007–2017 
Table 22: Mexico: HNWIs – Alternative Asset Composition (%), 2007–2017 
Table 23: Mexico: Trends in “Art, Wine and Wheels”, 2007–2012 
Table 24: Latin America: Residential Real Estate Prices (US$ per square meter), 2012 
Table 25: Global: Prime Residential Real Estate Prices (US$ per square meter), 2012 
Table 26: Global: Prime International Cities Performance (%), 2007–2012 
Table 27: Mexico: HNWIs – Percentages of Foreign Investment Allocation (%), 2007–2017 
Table 28: Mexico: HNWIs – Liquidity Breakdown (US$ Billion), 2007–2017 
Table 29: Mexico: HNWIs – Liquidity Breakdown (%), 2007–2017 
Table 30: Mexico: UHNWIs – Allocations and Share of HNWI Assets (%), 2012 
Table 31: Mexico: Major Private Banks by Local AuM (US$ Billion), 2012 
Table 32: Mexico: Other Private Banks, 2012 
Table 33: Mexico: Wealth Managers, 2012 
Table 34: Mexico: Wealth Managers per Major City, 2012 
Table 35: Mexico: LC to US$ Exchange Rate, 2007–2017 
Table 36: Mexico: Real GDP Growth, 2007–2017 
Table 37: Mexico: GDP Per Capita, 2007–2017 
Table 38: Mexico: Domestic Market Capitalization (US$ Billion), 2007–2011 
Table 39: Mexico: Commodity Indices, 2007–2017 
Table 40: Mexico: Foreign Direct Investment (US$ Billion), 2007–2017 
Table 41: Mexico: Inflation Rate, 2007–2017 
Table 42: Mexico: Benchmark Interest Rate, 2007–2017 
Table 43: Mexico: Balance of Payments (US$ Billion), 2007–2012 
Table 44: Mexico: Stock Market Performance, 2007–2012 
Table 45: Mexico: HNWI Wealth vs GDP Ratio (%), 2007–2017 
Table 46: Mexico: Appendix 1 
Table 47: Mexico: Appendix 2 

List of Figures


Figure 1: HNWI Wealth Band Definitions 
Figure 2: Map of Mexico 
Figure 3: Mexico: Asset Price Performance (%), 2007–2012 
Figure 4: Mexico: HNWI Performance, 2007–2017 
Figure 5: Mexico: Mexican HNWIs vs the World 
Figure 6: Mexico: HNWIs – Growth Factor Correlation, 2007–2012 
Figure 7: Mexico: HNWIs – Volume Distribution Wealth Pyramid, 2012 
Figure 8: Mexico: HNWIs – Wealth Distribution Wealth Pyramid (% share), 2012 
Figure 9: Mexico: HNWIs – Age Distribution (%), 2012 
Figure 10: Mexico: UHNWIs – Wealth Share vs Volume Growth (%), 2007–2012 
Figure 11: Mexico: UHNWIs – Volume by Wealth Band, 2007–2017 
Figure 12: Mexico: UHNWIs – Wealth by Wealth Band (US$ Billion), 2007–2017 
Figure 13: Mexico: UHNWIs – Age Distribution (% Share), 2012 
Figure 14: Mexico: HNWIs – Job Titles (%), 2012 
Figure 15: Mexico: UHNWIs – Distribution by Industry (%), 2012 
Figure 16: Mexico: Billionaires – Market Overview, 2007–2017 
Figure 17: Mexico: Centimillionaires – Market Overview, 2007–2017 
Figure 18: Mexico: Affluent Millionaires – Market Overview, 2007–2017 
Figure 19: Mexico: Mid-Tier Millionaires – Market Overview, 2007–2017 
Figure 20: Mexico: Lower-Tier Millionaires – Market Overview, 2007–2017 
Figure 21: Mexico: HNWIs – Asset Class Composition (%), 2007–2017 
Figure 22: Mexico: HNWIs – Trends in Alternative Assets (US$ Billion), 2007–2017 
Figure 23: Mexico: HNWIs – Trends in “Art, Wine and Wheels”, 2007–2012 
Figure 24: Mexico: HNWIs – Foreign Investment Allocation and Growth (%), 2012–2017 
Figure 25: Mexico: HNWIs – Global Distribution of Foreign Investments (%), 2007–2017 
Figure 26: Mexico: HNWIs – Liquidity Breakdown (%), 2007–2017 
Figure 27: Mexico: UHNWIs – Asset Class Composition (%), 2007–2017 
Figure 28: Mexico: Wealth Management Industry – Maturity Level of Players 
Figure 29: Mexico: Wealth Management Industry – Behavioral Mapping, 2012 
Figure 30: Mexico: LC to US$ Exchange Rate, 2007–2017 
Figure 31: Mexico: Real GDP Growth (%), 2007–2017 
Figure 32: Mexico: GDP Per Capita, 2007–2017 
Figure 33: Mexico: Domestic Market Capitalization (US$ Billion), 2007–2011 
Figure 34: Mexico: Commodity Indices, 2007–2017 
Figure 35: Mexico: Foreign Direct Investment (US$ Billion), 2007–2017 
Figure 36: Mexico: Inflation Rate, 2007–2017 
Figure 37: Mexico: Benchmark Interest Rate, 2007–2017 
Figure 38: Mexico: Balance of Payments (US$ Billion), 2007–2012 
Figure 39: Mexico: Stock Market Performance, 2007–2012 
Figure 40: Mexico: HNWI Wealth vs GDP Ratio (%), 2007–2017 
Figure 41: Mexico: HNWIs – Volume by Wealth Band, 2007–2017
Figure 42: Mexico: HNWIs – Wealth by Wealth Band (US$ Billion), 2007–2017 
Figure 43: Mexico: HNWIs – Wealth per Capita (US$ Billion), 2007–2017 

Upcoming Reports:

Dental Pain Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Dental pain, also referred as toothache is characterized by painful sensation in the teeth or its supporting structures which can be caused by a dental disease or a non-dental disease. Most common causes of toothache are dental cavity (pulpitis), gum disease, a damaged filling, tooth decay, tooth fracture, abscessed tooth, apical periodontitis, and alveolar osteitis. Non-dental causes include muscle pain, maxillary sinusitis, angina pectoris, psychological disorders and tumors. Pain on drinking hot or cold beverages, pain during chewing food, sensitivity of teeth, discoloration of the...
Nano-Biotechnology Market - Global Forecast, Market Share, Size, Growth And Industry Analysis (2011 - 2017)
By - Transparency Market Research
The branch of nanotechnology that deals with the study of biological and biochemical applications is known as nano-biotechnology. It is a detailed study mostly of classifying the elements of living things or organisms and then modifying the same into nano products. Nano-biotechnology stimulates new developments in the field of biotechnology. Biological research coupled with nano-technology continuously leads to the development of new inventions. The formulation of concepts in nano-biotechnology involves the following: Devices Particles Scale Clearly...
Poland: beef meat market
By - Williams and Marshal Strategy
dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market participants, the price fluctuations, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview of the economy of Poland in 2008-2012 and a forecast for its development in the medium term. The report on the beef meat market in Poland includes:...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...